A class action was filed in September 2011 against Takeda Pharmaceuticals and Eli Lilly, the manufacturers of the diabetic drug, Actos. The lawsuit was filed in the U.S. District Court for the Eastern District of Louisiana on behalf of two individuals who developed bladder cancer after taking Actos. The complaint also seeks class certification to include coverage for the millions of individuals who used Actos in the United States since it was marketed in 1999.
If you feel you have experienced adverse side-effects from taking Actos, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the manufacturers of Actos.